Chemours Company (The) (CC) Q3 2026 earnings — TrendMatrix coverage

Adjusted EPS

$0.21

Estimate

$0.26

Surprise

-18.5%

Score today

5.3/10

Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.

Chemours Company (The) (CC) missed the $0.26 estimate with adjusted EPS of $0.21 — a large 18.5% shortfall.

• Chemours Narrows FY2026 Sales Guidance from $5.866B-$6.098B to $5.924B vs $5.917B Est — benzinga, 2026-11-02
• Chemours Sees Q4 Sales $1.671B-$1.750B vs $1.421B Est — benzinga, 2026-11-02
• Chemours Q3 Adj. EPS $0.21 Misses $0.27 Estimate, Sales $1.540B Inline — benzinga, 2026-11-02

TrendMatrix currently rates CC Sell at 5.3/10; no pre/post engine snapshot brackets this report.

2 of the last 4 quarters beat the estimate; this quarter's -18.5% surprise compares with a +99.3% four-quarter average.

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current price

$13.16

Price target

$14.36

Stop

$12.24

Upside to target

+9.1%

Reward-to-risk

1.2:1

Model outputs from TrendMatrix’s engine as of 2026-11-03 — shown for context, not personalized investment advice.

Materials producers report against the commodity cycle — realized-price capture and volume, not the EPS line, are the tells in a quarter like this.

Industry

Specialty Chemicals

Market cap

$1.98B

P/E (fwd)

7.1

52-week range

$10.44–$28.67

Off 52-week high

54.1%

RSI (14)

49

Volume vs avg

1.94×

Score today

5.3/10